Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph early_phase_1
2
50%
Ph phase_1
1
25%
Ph phase_2
1
25%

Phase Distribution

3

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Other(3)

Detailed Status

unknown2
Recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (50.0%)
Phase 11 (25.0%)
Phase 21 (25.0%)

Trials by Status

recruiting125%
unknown250%
suspended125%

Recent Activity

Clinical Trials (4)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4